Tsingke Biotech Showcases Innovations at Leading Oncology Event
Tsingke Biotech proudly featured its cutting-edge innovations at the AACR Annual Meeting 2025, a pivotal event for oncology research. The meeting gathered leaders from across the globe to engage in discussions about the future of cancer diagnostics and therapeutics.
Highlighting Comprehensive Synthesis Services
At Booth #3255, Tsingke showcased its extensive synthesis and expression service portfolio, which supports projects from the initial discovery phase through to preclinical development. The presentation focused on their advanced capabilities in gene synthesis, oligonucleotide production, mRNA technologies, and protein expression.
Exceptional Offerings for Oncology Research
High-Throughput Nucleic Acid Synthesis
Tsingke provides a range of custom DNA and RNA oligonucleotides, including siRNA and ASOs. Their high-throughput services enable complex modifications such as LNA and phosphorothioate, ensuring qPCR and NGS-grade primer and probe production.
Robust mRNA Synthesis Services
Additionally, Tsingke offers mRNA synthesis paired with a supply of raw materials, including IVT template synthesis with necessary modifications. Their high-purity enzymes and capping reagents streamline LNP formulation workflows, catering to a variety of research needs.
Advanced Protein Expression Tools
The company also excels in protein expression and antibody tools, offering services from gene synthesis to vector construction and validation of expression. Fast-turnaround expression services in HEK293 and CHO systems ensure timely support for research initiatives.
Customized Research and Development Support
Tsingke's commitment to custom R&D support includes providing sgRNA libraries and tools for gene editing and RNAi constructs, empowering researchers to develop novel therapies for challenging conditions.
Building a Sustainable Synthesis Engine for Cancer Innovation
With a mission to serve biotech companies, CDMOs, and academic researchers, Tsingke is dedicated to creating a centralized synthesis platform. By streamlining processes from molecular design and synthesis to expression and functional validation, they are paving the way for accelerated advancement in target discovery and preclinical development.
Elevating Cancer Research Through Partnership
Tsingke fosters collaborations that enhance the journey from laboratory innovation to clinical application. Their goal is to contribute significantly to the global fight against cancer by enabling researchers with the tools they need to succeed.
Contact Tsingke for Personalized Solutions
If you are interested in learning more about Tsingke's innovative solutions or discussing custom projects, feel free to reach out directly to their team. A dedicated staff member is ready to assist you in exploring how their offerings can support your specific research goals.
Frequently Asked Questions
What is the focus of Tsingke's offerings at AACR Annual Meeting?
Tsingke's focus includes advanced synthesis and expression services tailored for oncology research, from discovery to preclinical stages.
What types of nucleic acids can Tsingke synthesize?
Tsingke provides custom DNA and RNA oligonucleotides, including complex modifications necessary for various research applications.
How does Tsingke support mRNA synthesis?
Tsingke offers comprehensive services for mRNA synthesis including raw materials and IVT template synthesis, ensuring high quality and efficiency.
What protein expression services does Tsingke provide?
The company offers gene synthesis, vector construction, and rapid expression services in HEK293/CHO systems to facilitate research.
How can researchers collaborate with Tsingke?
Researchers can contact Tsingke for personalized solutions and discuss how the company can assist in their projects through custom offerings.
